+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Critical Care Therapeutics - Global Market Trajectory & Analytics

  • ID: 5140868
  • Report
  • September 2020
  • Region: Global
  • 280 pages
  • Global Industry Analysts, Inc
Global Critical Care Therapeutics Market to Reach $3.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Critical Care Therapeutics estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027. Albumin, one of the segments analyzed in the report, is projected to record a 3% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Prothrombin Complex Concentrates segment is readjusted to a revised 2.1% CAGR for the next 7-year period.

The U. S. Market is Estimated at $785.8 Million, While China is Forecast to Grow at 4.9% CAGR

The Critical Care Therapeutics market in the U. S. is estimated at US$785.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$700.3 Million by the year 2027 trailing a CAGR of 4.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 1.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Antithrombin Concentrates Segment to Record 2.3% CAGR

In the global Antithrombin Concentrates segment, USA, Canada, Japan, China and Europe will drive the 1.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$260.9 Million in the year 2020 will reach a projected size of US$298 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$475 Million by the year 2027, while Latin America will expand at a 3.2% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 280-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Abeona Therapeutics Inc.
  • ADMA Biologics, Inc.
  • Albumedix Ltd.
  • Asklepios Biopharmaceutical, Inc.
  • Aspen Pharmacare Holdings Ltd.
  • Baxter International Inc.
  • Bayer Healthcare AG
  • Bio Products Laboratory Ltd.
  • BioDelivery Sciences International, Inc.
  • Biogen, Inc.
  • BioMarin Pharmaceutical Inc.
  • Biotest Pharmaceuticals Corporation
  • Bristol-Myers Squibb Company
  • Catalyst Biosciences, Inc.
  • China Biologic Products Holdings, Inc.
  • Cosmo Pharmaceuticals NV
  • CSL Behring
  • Grifols International SA
  • Kamada Ltd.
  • Kedrion Biopharma, Inc.
  • Medxbio Pte. Ltd.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novo Nordisk A/S
  • Novozymes A/S
  • Octapharma AG
  • Portola Pharmaceuticals, Inc.
  • ProMetic Life Sciences, Inc.
  • rEVO Biologics, Inc.
  • Rockwell Medical
  • Sanquin
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shire PLC
  • Teva Pharmaceutical Industries Ltd.
  • The Medicines Company
  • Thermo Fisher Scientific, Inc.
  • Ventria Bioscience
Note: Product cover images may vary from those shown
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Critical Care Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Critical Care Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Critical Care Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Critical Care Therapeutics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Albumin (Drug Class) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Albumin (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Albumin (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Prothrombin Complex Concentrates (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Prothrombin Complex Concentrates (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Prothrombin Complex Concentrates (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Antithrombin Concentrates (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Antithrombin Concentrates (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Antithrombin Concentrates (Drug Class) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Other Drug Classes (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Other Drug Classes (Drug Class) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Other Drug Classes (Drug Class) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Deep Vein Thrombosis (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 17: Deep Vein Thrombosis (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 18: Deep Vein Thrombosis (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Pulmonary Embolism (PE) (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 20: Pulmonary Embolism (PE) (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 21: Pulmonary Embolism (PE) (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Acute Coronary Syndrome (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Acute Coronary Syndrome (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Acute Coronary Syndrome (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 26: Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 27: Other Applications (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Critical Care Therapeutics Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 28: United States Critical Care Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2020 to 2027
  • TABLE 29: Critical Care Therapeutics Market in the United States by Drug Class: A Historic Review in US$ Million for 2012-2019
  • TABLE 30: United States Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 31: United States Critical Care Therapeutics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 32: Critical Care Therapeutics Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
  • TABLE 33: Critical Care Therapeutics Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
CANADA
  • TABLE 34: Canadian Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020 to 2027
  • TABLE 35: Canadian Critical Care Therapeutics Historic Market Review by Drug Class in US$ Million: 2012-2019
  • TABLE 36: Critical Care Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2012, 2020, and 2027
  • TABLE 37: Canadian Critical Care Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 38: Critical Care Therapeutics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 39: Canadian Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
JAPAN
  • TABLE 40: Japanese Market for Critical Care Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 41: Critical Care Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2012-2019
  • TABLE 42: Japanese Critical Care Therapeutics Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 43: Japanese Demand Estimates and Forecasts for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 44: Japanese Critical Care Therapeutics Market in US$ Million by Application: 2012-2019
  • TABLE 45: Critical Care Therapeutics Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
CHINA
  • TABLE 46: Chinese Critical Care Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 47: Critical Care Therapeutics Historic Market Analysis in China in US$ Million by Drug Class: 2012-2019
  • TABLE 48: Chinese Critical Care Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 49: Chinese Demand for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 50: Critical Care Therapeutics Market Review in China in US$ Million by Application: 2012-2019
  • TABLE 51: Chinese Critical Care Therapeutics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European Critical Care Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 52: European Critical Care Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 53: Critical Care Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 54: European Critical Care Therapeutics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 55: European Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020-2027
  • TABLE 56: Critical Care Therapeutics Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2012-2019
  • TABLE 57: European Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 58: European Critical Care Therapeutics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 59: Critical Care Therapeutics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 60: European Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 61: Critical Care Therapeutics Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 62: French Critical Care Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2012-2019
  • TABLE 63: French Critical Care Therapeutics Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 64: Critical Care Therapeutics Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
  • TABLE 65: French Critical Care Therapeutics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 66: French Critical Care Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
  • TABLE 67: Critical Care Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 68: German Critical Care Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2012-2019
  • TABLE 69: German Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 70: Critical Care Therapeutics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 71: German Critical Care Therapeutics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 72: Critical Care Therapeutics Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
ITALY
  • TABLE 73: Italian Critical Care Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 74: Critical Care Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Class: 2012-2019
  • TABLE 75: Italian Critical Care Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 76: Italian Demand for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 77: Critical Care Therapeutics Market Review in Italy in US$ Million by Application: 2012-2019
  • TABLE 78: Italian Critical Care Therapeutics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
  • TABLE 79: United Kingdom Market for Critical Care Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 80: Critical Care Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2012-2019
  • TABLE 81: United Kingdom Critical Care Therapeutics Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 82: United Kingdom Demand Estimates and Forecasts for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 83: United Kingdom Critical Care Therapeutics Market in US$ Million by Application: 2012-2019
  • TABLE 84: Critical Care Therapeutics Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
SPAIN
  • TABLE 85: Spanish Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020 to 2027
  • TABLE 86: Spanish Critical Care Therapeutics Historic Market Review by Drug Class in US$ Million: 2012-2019
  • TABLE 87: Critical Care Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2012, 2020, and 2027
  • TABLE 88: Spanish Critical Care Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 89: Critical Care Therapeutics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 90: Spanish Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
RUSSIA
  • TABLE 91: Russian Critical Care Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2020 to 2027
  • TABLE 92: Critical Care Therapeutics Market in Russia by Drug Class: A Historic Review in US$ Million for 2012-2019
  • TABLE 93: Russian Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 94: Russian Critical Care Therapeutics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 95: Critical Care Therapeutics Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019
  • TABLE 96: Critical Care Therapeutics Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 97: Rest of Europe Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020-2027
  • TABLE 98: Critical Care Therapeutics Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2012-2019
  • TABLE 99: Rest of Europe Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 100: Rest of Europe Critical Care Therapeutics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 101: Critical Care Therapeutics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 102: Rest of Europe Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 103: Asia-Pacific Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 104: Critical Care Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 105: Asia-Pacific Critical Care Therapeutics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 106: Critical Care Therapeutics Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 107: Asia-Pacific Critical Care Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2012-2019
  • TABLE 108: Asia-Pacific Critical Care Therapeutics Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 109: Critical Care Therapeutics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
  • TABLE 110: Asia-Pacific Critical Care Therapeutics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 111: Asia-Pacific Critical Care Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
AUSTRALIA
  • TABLE 112: Critical Care Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 113: Australian Critical Care Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2012-2019
  • TABLE 114: Australian Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 115: Critical Care Therapeutics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 116: Australian Critical Care Therapeutics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 117: Critical Care Therapeutics Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027
INDIA
  • TABLE 118: Indian Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020 to 2027
  • TABLE 119: Indian Critical Care Therapeutics Historic Market Review by Drug Class in US$ Million: 2012-2019
  • TABLE 120: Critical Care Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Class for 2012, 2020, and 2027
  • TABLE 121: Indian Critical Care Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 122: Critical Care Therapeutics Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 123: Indian Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
SOUTH KOREA
  • TABLE 124: Critical Care Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 125: South Korean Critical Care Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2012-2019
  • TABLE 126: Critical Care Therapeutics Market Share Distribution in South Korea by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 127: Critical Care Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
  • TABLE 128: South Korean Critical Care Therapeutics Historic Market Analysis in US$ Million by Application: 2012-2019
  • TABLE 129: Critical Care Therapeutics Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
  • TABLE 130: Rest of Asia-Pacific Market for Critical Care Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 131: Critical Care Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2012-2019
  • TABLE 132: Rest of Asia-Pacific Critical Care Therapeutics Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 133: Rest of Asia-Pacific Demand Estimates and Forecasts for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 134: Rest of Asia-Pacific Critical Care Therapeutics Market in US$ Million by Application: 2012-2019
  • TABLE 135: Critical Care Therapeutics Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027
LATIN AMERICA
  • TABLE 136: Latin American Critical Care Therapeutics Market Trends by Region/Country in US$ Million: 2020-2027
  • TABLE 137: Critical Care Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
  • TABLE 138: Latin American Critical Care Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
  • TABLE 139: Latin American Critical Care Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 140: Critical Care Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Class: 2012-2019
  • TABLE 141: Latin American Critical Care Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 142: Latin American Demand for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 143: Critical Care Therapeutics Market Review in Latin America in US$ Million by Application: 2012-2019
  • TABLE 144: Latin American Critical Care Therapeutics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
ARGENTINA
  • TABLE 145: Argentinean Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020-2027
  • TABLE 146: Critical Care Therapeutics Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2012-2019
  • TABLE 147: Argentinean Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 148: Argentinean Critical Care Therapeutics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 149: Critical Care Therapeutics Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 150: Argentinean Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
BRAZIL
  • TABLE 151: Critical Care Therapeutics Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 152: Brazilian Critical Care Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2012-2019
  • TABLE 153: Brazilian Critical Care Therapeutics Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 154: Critical Care Therapeutics Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027
  • TABLE 155: Brazilian Critical Care Therapeutics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 156: Brazilian Critical Care Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
MEXICO
  • TABLE 157: Critical Care Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 158: Mexican Critical Care Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2012-2019
  • TABLE 159: Mexican Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 160: Critical Care Therapeutics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 161: Mexican Critical Care Therapeutics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 162: Critical Care Therapeutics Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
  • TABLE 163: Rest of Latin America Critical Care Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2020 to 2027
  • TABLE 164: Critical Care Therapeutics Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2012-2019
  • TABLE 165: Rest of Latin America Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 166: Rest of Latin America Critical Care Therapeutics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 167: Critical Care Therapeutics Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019
  • TABLE 168: Critical Care Therapeutics Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027
MIDDLE EAST
  • TABLE 169: The Middle East Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 170: Critical Care Therapeutics Market in the Middle East by Region/Country in US$ Million: 2012-2019
  • TABLE 171: The Middle East Critical Care Therapeutics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
  • TABLE 172: The Middle East Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020 to 2027
  • TABLE 173: The Middle East Critical Care Therapeutics Historic Market by Drug Class in US$ Million: 2012-2019
  • TABLE 174: Critical Care Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2012,2020, and 2027
  • TABLE 175: The Middle East Critical Care Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 176: Critical Care Therapeutics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 177: The Middle East Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
IRAN
  • TABLE 178: Iranian Market for Critical Care Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 179: Critical Care Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2012-2019
  • TABLE 180: Iranian Critical Care Therapeutics Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 181: Iranian Demand Estimates and Forecasts for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 182: Iranian Critical Care Therapeutics Market in US$ Million by Application: 2012-2019
  • TABLE 183: Critical Care Therapeutics Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027
ISRAEL
  • TABLE 184: Israeli Critical Care Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2020-2027
  • TABLE 185: Critical Care Therapeutics Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2012-2019
  • TABLE 186: Israeli Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 187: Israeli Critical Care Therapeutics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 188: Critical Care Therapeutics Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 189: Israeli Critical Care Therapeutics Market Share Analysis by Application: 2012 VS 2020 VS 2027
SAUDI ARABIA
  • TABLE 190: Saudi Arabian Critical Care Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 191: Critical Care Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2012-2019
  • TABLE 192: Saudi Arabian Critical Care Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 193: Saudi Arabian Demand for Critical Care Therapeutics in US$ Million by Application: 2020 to 2027
  • TABLE 194: Critical Care Therapeutics Market Review in Saudi Arabia in US$ Million by Application: 2012-2019
  • TABLE 195: Saudi Arabian Critical Care Therapeutics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
  • TABLE 196: Critical Care Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 197: United Arab Emirates Critical Care Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2012-2019
  • TABLE 198: Critical Care Therapeutics Market Share Distribution in United Arab Emirates by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 199: Critical Care Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
  • TABLE 200: United Arab Emirates Critical Care Therapeutics Historic Market Analysis in US$ Million by Application: 2012-2019
  • TABLE 201: Critical Care Therapeutics Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
  • TABLE 202: Critical Care Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2020-2027
  • TABLE 203: Rest of Middle East Critical Care Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2012-2019
  • TABLE 204: Rest of Middle East Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 205: Critical Care Therapeutics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 206: Rest of Middle East Critical Care Therapeutics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 207: Critical Care Therapeutics Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027
AFRICA
  • TABLE 208: African Critical Care Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2020 to 2027
  • TABLE 209: Critical Care Therapeutics Market in Africa by Drug Class: A Historic Review in US$ Million for 2012-2019
  • TABLE 210: African Critical Care Therapeutics Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027
  • TABLE 211: African Critical Care Therapeutics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 212: Critical Care Therapeutics Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019
  • TABLE 213: Critical Care Therapeutics Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 37
Note: Product cover images may vary from those shown
Adroll
adroll